Background

Dr. Dennis H. Langer, M.D., J.D., serves as the Chief Executive Officer of AdvanDx, Inc. Dr. Langer serves as a Clinical Professor in Department of Psychiatry at Georgetown University School of Medicine in Washington, DC. He served at Abbott Laboratories. He served as an Associate Clinical Investigator at Eli Lilly and Company from 1983 to 1984. From 2005 to 2010, Dr. Langer served as the Managing Partner of Phoenix IP Ventures. He served as a Senior Vice President of ... Project and Portfolio Management and Senior Vice President of Research and Development at GlaxoSmithKline Plc from December 2000 to January 2004. Dr. Langer was with GlaxoSmithKline since 1994. He also co-founded Iroko Pharmaceuticals, LLC. Dr. Langer served as the President of North American Operations at Dr. Reddy's Laboratories Ltd. from January 20, 2004 to July 8, 2005. In addition, he led the alliance and joint venture management function at Dr. Reddy's Laboratories. Dr. Langer held a variety of management positions involving increasing responsibility in the areas of global product development strategy, healthcare services, and business strategy at Dr. Reddy's Laboratories. He served as a Senior Vice President of Product Development Strategy and Senior Vice President of Research and Development, Healthcare Services with SmithKline Beecham Limited. Dr. Langer served as the President and Chief Executive Officer of Neose Technologies, Inc. from 1991 to 1994. He served as the Chief Resident in Psychiatry at Yale University School of Medicine and held clinical fellowships in Psychiatry at Harvard Medical School, George Washington University School of Medicine, and the National Institutes of Health. Dr. Langer has a broad base of experience in innovative research and development, commercial operations, and business development gained through senior management positions with major pharmaceutical companies such as Eli Lilly, Abbott Laboratories, and G. D. Searle, LLC. He has an extensive pharmaceutical company background. He serves as the Chairman of The Board at Light Sciences Oncology, Inc. and has been its Director since May 11, 2011. Dr. Langer serves as the Chairman of Scientific Advisory Board at InforMedix Holdings Inc. He served as Chairman of AdvanDx, Inc. and serves as its Director. He serves as a Director of various public and private biotechnology, specialty pharmaceutical, and diagnostic companies. He has been a Director of Sancilio & Company, Inc. since July 2012. He serves as a Director of Myriad Genetics Inc. Dr. Langer has been a Director of Sirna Therapeutics, Inc. since August 2005. He has been a Director of Dicerna Pharmaceuticals, Inc. since November 2007 and Delcath Systems, Inc. since December 2014. He has been a Member of Scientific Advisory Board of iCeutica Inc. since June 20, 2005. He serves as a Director of Biotechnology Industry Organization and Alliance for Aging Research. He serves as a Member of Advisory Board of Investor Growth Capital. He serves on the Boards of Visitors at Columbia College and Columbia University. Dr. Langer served as a Member of Healthcare Advisory Board at Safeguard Scientifics, Inc. and had also served as a Member of its Life Sciences Advisory Board. He served as a Director of Myrexis, Inc. from February 19, 2009 to January 23, 2013. He served as a Director at Auxilium Pharmaceuticals, Inc. from July 2007 to June 2010. He served as a Director of EUSA Pharma (USA), Inc. from June 14, 2005 to May 8, 2008 and Pharmacopeia, Inc. from May 7, 2007 to December 2008. Dr. Langer served as a Director of Shire Human Genetic Therapies Inc. since November 2003. He served as a Director of Iroko Pharmaceuticals, LLC. He served as a Director of Inotek Pharmaceuticals Corporation since February 14, 2007. Dr. Langer served as a Director of Ception Therapeutics, Inc. He served as a Director of Innocoll GmbH (also known as Innocoll AG). He has published over 30 articles in peer reviewed medical journals. He has over 25 years of experience in the pharmaceutical/biotechnology industry. Dr. Langer received a J.D., cum laude, from Harvard Law School, an M.D. from Georgetown University School of Medicine, and a B.A. in Biology from Columbia University.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.